Product Name: K-ras Gene Mutations Detection Kit
Pack Size:10 Tests/Kit
Instruments Validated:Stratagene Mx3000P™,ABI7500,Biorad CFX96
Sample Type:Tumor tissue,Peripheral blood,Pleural and ascites
DETECTED GENES
1.G12D
2.G12A 9.Q61L,Q61R,Q61H,A59T,Q61K,A146T,A146V,A146P
3. G12V
4. G12S
5. G12R
6. G12C
7. G13D
8.G13C,G13S,G13R,K117N,K117N
9.Q61L,Q61R,Q61H,A59T,Q61K,A146T,A146V,A146P
DETECTION SIGNIFICANCE
1. It is recommended to detect KRAS gene status before systemic treatment for patients with inoperable stage III and IV NSCLC to guide the treatments according to molecular classification. If tissue samples are not available, circulating tumor DNA can be considered for testing.
2. It is recommended to detect KRAS gene status for the potentially resectable group of metastatic colorectal cancer before neoadjuvant chemotherapy or systemic treatment in the palliative care group. The mutation patients are resistant to Cetuximab, Panitumumab and Anti-HER-2 therapies.